SGI-DNA, a wholly owned subsidiary of Synthetic Genomics Inc. (SGI), announced that Fernanda Gandara has assumed the role of General Manager for company and will remain as SGI's Senior Vice President for Business Development.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.08 USD | +11.32% | +18.26% | -43.19% |
05-09 | Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M | MT |
05-09 | Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.19% | 6.17M | |
+7.01% | 215B | |
+11.01% | 187B | |
+19.20% | 143B | |
+30.79% | 110B | |
+1.48% | 64.68B | |
+13.95% | 52.96B | |
-0.16% | 49.84B | |
-6.20% | 38.32B | |
+0.91% | 35.86B |
- Stock Market
- Equities
- TBIO Stock
- News Telesis Bio, Inc.
- SGI-DNA Appoints Fernanda Gandara as General Manager